Published 7 days ago • loading... • Updated 4 days ago

FDA nominee sidesteps questions on abortion pill, agency layoffs and other issues

Dr. Marty Makary, a nominee for FDA commissioner, emphasized he would rely on scientific data if confirmed, stating he wants to restore trust in the FDA and its products.
Makary did not directly address questions about mifepristone access and FDA layoffs, saying he would conduct assessments upon taking office.
Makary acknowledged high prescription drug prices as an issue, noting the importance of public trust in medication efficacy.
Makary criticized the FDA for past decisions and stated that addressing childhood obesity and health issues should be a priority, linking many to food additives.

Insights by Ground AI

Does this summary seem wrong?

79 Articles

All

Left

Center

Right

Wisconsin Examiner

Trump nominee to head up FDA won’t make any commitments on abortion pill access • Wisconsin Examiner

Makaray says he will review data on mifepristone and follow the research where it leads him, with no preconceived ideas about the outcome.

5 days ago

Read Full Article

The Daily Signal

FDA Nominee Makary Calls for ‘More Humility in the Medical Establishment’

In his confirmation hearing to be commissioner of the Food and Drug Administration, Dr. Martin Makary on Thursday decried the hubris of the medical establishment that he said was leading to a distrust of medical professionals by the American public. “We need more humility in the medical establishment,” Makary told the Senate Committee on Health, Education, Labor, and Pensions, which also heard the testimony of Trump’s nominee to lead the Nation…

5 days ago·Washington, United States

Read Full Article

The Thinking Conservative

5 Takeaways From FDA Nominee Marty Makary’s Hearing - The Thinking Conservative

Dr. Marty Makary, nominee to lead FDA, appeared before the Senate Health, Education, Labor, and Pensions Committee at a confirmation hearing on March 6. The post 5 Takeaways From FDA Nominee Marty Makary’s Hearing appeared first on The Thinking Conservative.

5 days ago

Read Full Article

kffhealthnews.org

Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against

Panelists at a covid conference last fall were asked to voice their regrets — policies they had supported during the pandemic but had come to see as misguided. Covid contact tracing, one said. Closing schools, another said. Vaccine mandates, a third said. When Marty Makary’s turn came, the Johns Hopkins University surgeon said, “I can’t think of anything,” adding, “The entire covid policy of three to four years felt like a horror movie I was for…

6 days ago

Read Full Article

PharmaVOICE

How will Makary lead FDA amid workforce cuts and RFK Jr.s’ influence?

With President Trump’s nominee for FDA commissioner in Senate confirmation hearings, his approach to workforce cuts and other policies is under scrutiny.

6 days ago

Read Full Article

News & Record

FDA nominee evades abortion pill questions

President Donald Trump's pick to lead the Food and Drug Administration largely sidestepped questions Thursday from senators about how he would handle numerous pressing issues before the agency, including recent layoffs, a canceled vaccine meeting and the continued availability of…

6 days ago·Cherokee County, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year